Review
doi: 10.1016/s0193-953x(05)70345-2.
Huntington's disease
Affiliations
- PMID: 9443350
- DOI: 10.1016/s0193-953x(05)70345-2
Item in Clipboard
Review
Huntington's disease
Psychiatr Clin North Am.
1997 Dec.
Free article
Abstract
Huntington's disease is a genetically inherited degenerative neuropsychiatric disorder, characterized by motor alterations, including involuntary movements such as chorea, dementia and psychiatric disturbances. In this article, the authors review the clinical features of the disease. They also analyze some genetic and pathophysiologic aspects, that can help to improve our understanding of this disorder involving the basal ganglia.
Similar articles
-
Pathophysiology of chorea and bradykinesia in Huntington's disease.Mov Disord. 1999 May;14(3):398-403. doi: 10.1002/1531-8257(199905)14:3<398::aid-mds1003>3.0.co;2-f. Mov Disord. 1999. PMID: 10348461 Review.
-
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7. Neuroscience. 2000. PMID: 10828533
-
[Current perspectives in the treatment of Huntington's chorea].Neurol Neurochir Pol. 2002 Jul-Aug;36(4):757-65. Neurol Neurochir Pol. 2002. PMID: 12418139 Review. Polish.
-
Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.Australas Psychiatry. 2018 Aug;26(4):366-375. doi: 10.1177/1039856218791036. Epub 2018 Jul 16. Australas Psychiatry. 2018. PMID: 30012004 Review.
-
The Neuropsychology of Huntington's Disease.Arch Clin Neuropsychol. 2017 Nov 1;32(7):876-887. doi: 10.1093/arclin/acx086. Arch Clin Neuropsychol. 2017. PMID: 28961886 Review.
Cited by
-
Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects.Clin Transl Oncol. 2022 Feb;24(2):203-214. doi: 10.1007/s12094-021-02702-w. Epub 2021 Sep 26. Clin Transl Oncol. 2022. PMID: 34564830 Review.
-
Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.PLoS One. 2018 Aug 17;13(8):e0200626. doi: 10.1371/journal.pone.0200626. eCollection 2018. PLoS One. 2018. PMID: 30118496 Free PMC article.
-
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.Neurol Ther. 2024 Jun;13(3):655-675. doi: 10.1007/s40120-024-00600-1. Epub 2024 Apr 1. Neurol Ther. 2024. PMID: 38557959 Free PMC article.
-
Preclinical Huntington's disease: compensatory brain responses during learning.Ann Neurol. 2006 Jan;59(1):53-9. doi: 10.1002/ana.20684. Ann Neurol. 2006. PMID: 16261565 Free PMC article.
-
Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.J Neurosci. 2018 May 16;38(20):4678-4694. doi: 10.1523/JNEUROSCI.0434-18.2018. Epub 2018 Apr 24. J Neurosci. 2018. PMID: 29691329 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
